![Alexey Vinogradov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 54 356 $ al 30/06/2026
Dr. Alexey A. Vinogradov is an Independent Non-Executive Director at Xenetic Biosciences, Inc. and a Director-Operations & Business Development at Cantreva LLC.
He is on the Board of Directors at Pharmsynthez PJSC, Xenetic Biosciences, Inc. and Avelas Biosciences, Inc. Dr. Vinogradov was previously employed as a General Manager by Togas Middle East LLC, an Independent Director by Argos Therapeutics, Inc., a Branch Manager by Togas Group LLC, a Managing Partner by Pharmstandard Ventures, and an Investment Manager by Bioprocess Capital Partners Ltd. He received his doctorate degree from Moscow State University Lomonosov.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 18.679 ( 0,82 % ) | 54 356 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Director/Miembro de la Junta | 19/07/2019 |
| PHARMSYNTHEZ | Director/Miembro de la Junta | 03/08/2023 |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Director/Miembro de la Junta | 14/03/2017 |
Cantreva LLC | Director de Operaciones | 01/09/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Togas Middle East LLC | Corporate Officer/Principal | 01/05/2017 |
Togas Group LLC | Corporate Officer/Principal | 01/11/2016 |
| ARGOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 10/06/2016 |
Bioprocess Capital Partners Ltd.
 Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Inversor de Capital Privado | 31/12/2010 |
Pharmstandard Ventures
 Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmsynthez PJSC
 Pharmsynthez PJSC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Finance |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Cantreva LLC | |
Togas Middle East LLC | |
Togas Group LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
